CPHI India and PMEC India are expanding their pharmaceutical expos to two venues in Delhi-NCR. This move aims to support the rapid growth o...

The US has slapped up to 100% tariffs on patented drugs, sparing generics and biosimilars but exposing India’s speciality pharma players. S...

Rx Propellant will invest $100 million in Hyderabad's Genome Valley. A new life sciences campus will be built over six years. This project ...

The arrests come after an FIR was lodged late Thursday night against five officials of Marion Biotech, including two of its directors, over...

Spiro, who had most recently served as president of Specialty Generics business at Mallinckrodt Pharmaceuticals and the president of US Inj...

"Covaxin was developed against the original Wuhan variant," a Bharat Biotech spokesperson told Reuters in a text message, referring to the ...

Biosimilar Etanercept is used to fight a range of severe auto-immune disorders.

National pharmaceutical institutes have signed 17 agreements with drug firms, including Dr Reddys, Sun Pharma and Wockhardt.

According to Nasdaq, the stock price of ISIS Pharmaceuticals crossed above its 200-day moving average for the first time since early spring.

ISIS Pharmaceuticals, a $4.3 billion biotech firm surged 10% today, and it's up 43% in the last three months.

The consultancy firm has also asked the government to allocate Rs 500 crore each year from the R&D cess accessible by the Technology Develo...

"The Biocon employer brand has been growing stronger with each passing year, and our increased success in attracting talent is a testimony ...

Companies based in Mumbai and other parts of western India dominate the Indian biotech sector, pushing Bangalore down to second place, a su...

India's biotech industry bounced to high growth in fiscal 2009-10 to post revenues of $4 billion, a whopping 52 per cent over the previous ...

The American company has just completed the $68-billion acquisition of biotech major Wyeth, which is a new drug developer.

Malladi Drugs and Pharmaceutical Ltd will invest up to USD 300 million over the next three to five years to set up its global "one-stop sho...

After establishing Kolkata as a top IT/ITeS destination, the West Bengal government intends to replicate that success in the biotech turf.